Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares from its current shareholders.
They have acquired 60,000 square feet of secured perimeter for its current production facility located on 150 acres. They have already submitted plans for additional buildings on the Property including a 30,000 square foot facility.
Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.
The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.
Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.
Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.
20,142.13 89.71 (0.45%) Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada BEVERLY HILLS, CA--(Marketwired - Feb 7, 2017) - Crown Baus Capital Corp. (the "Company") ( OTC PINK : CBCA ), is a global acquisition-based conglomerate looking to aggressively capitalize on its key industry strengths.
The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.
GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.
Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.
Aphria (TSXV:APH, OTC:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX.
QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.
The acquisitions include a 12,000 sq. ft. licensed medical marijuana cultivation/production facility and packaging center with over $1 million in medicinal sales in its first year of operation. The second acquisition is of a start-up company that develops and markets hemp based and CBD infused products for sales nationwide.
Tweed Inc. (OTC:TWMJF) triples its production capability with purchase of an old Hershey factory in Ontario, Canada. The 42-acre site is now the largest indoor cannabis production facility in Canada, and likely the world.
The building and property were acquired for $6.6 million, $923,980 of which was issued in shares. As a part owner of the facility prior to the transaction, Linton received 70,800 of the 94,397 shares issued.
The largest Cannabis companies had a combined market cap of $7 Billion at the end of 2016. We're looking for the "rising tide" affect on any companies that have not enjoyed the same momentum the sector has brought to the top 10 list here.
It’s not just thatPot Stocks are hot, but add Cannabis Biotech's to the fire and you get explosive wealth making opportunities… Of the 10 largest MJ Stocks (by market cap) nine are biotech/pharma firms and just one “touches the plant.”
dezembro 20, 2016 RM Consult comentários Turning High-Tech Into ‘High’ Tech: Behind Israel’s Blooming Medical Cannabis Industry Some of the recent studies coming out of Israel show that marijuana can heal bone fractures ; is able to relieve the pain associated with Parkinson’s disease; and that small quantities of cannabis can prevent brain damage , and even halt the spread of cancer .
The Volcani Center, the Ministry of Agriculture’s research organization, is building a national institute for medical marijuana research. The chief scientist’s office of the Ministry of Economy has infused millions of shekels into innovative marijuana companies, much as government investment helped fuel the Israeli tech boom in the 1990s. The government is also setting standards for the cultivation, storage and use of medical marijuana.
Canada will be the first major economy to fully legalize marijuana use. However, industry insiders say that’s just the starting point for the real opportunity in Canadian marijuana stocks.
